SCHEMBL6152288

SCHEMBL6152288

Cc1ccc(C)c2c1C(=O)c1c(C)ccc(C)c1C2=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.52
POR P16435 1/20 0.52
NSD2 O96028 2/20 0.50
TDP2 O95551 1/20 0.50
HSP90AA1 P07900 1/20 0.50
PAX8 Q06710 1/20 0.50
THRB P10828 1/20 0.47
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
NPC1 O15118 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.43
RAB9A P51151 1/20 0.43
HBB P68871 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13051339 0.88 NSD2 (0.48) NQO1PORNSD2TDP2HSP90AA1
SCHEMBL14750382 0.86 THRB (0.74) NQO1PORNSD2TDP2HSP90AA1
SCHEMBL14839396 0.86 THRB (0.74) NQO1PORNSD2TDP2HSP90AA1
SCHEMBL12110311 0.84 NQO1 (0.42) NQO1PORNSD2TDP2HSP90AA1
SCHEMBL13657177 0.84 CSNK2A2 (0.60) NQO1PORTHRBALDH1A1L3MBTL1
SCHEMBL11690019 0.80 MAPT (0.59) NQO1PORHSP90AA1THRBALDH1A1
SCHEMBL15676071 0.80 NQO1 (0.47) NQO1PORNSD2TDP2HSP90AA1
SCHEMBL30886455 0.80 ALDH1A1 (0.67) NSD2TDP2THRBALDH1A1L3MBTL1
SCHEMBL55743 0.80 ALDH1A1 (0.67) NSD2TDP2THRBALDH1A1L3MBTL1
SCHEMBL11799076 0.78 NQO1 (0.42) NQO1PORNSD2TDP2HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150307441-A1 NEW COMPOUNDS AND USES THEREOF BIOSTATUS LIMITED (GB) 2015-10-29 US disclosed
US-8906519-B2 Oligoaniline compounds NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-12-09 US disclosed
US-8906519-B2 Oligoaniline compounds NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-12-09 US disclosed
US-8058460-B2 Near infrared fluorophore for the selective labelling of membranes in cells Universität Heidelberg (DE) 2011-11-15 US disclosed
US-7915048-B2 Adding 1,4-di-(2-ethylhexylamino)-5,8-dihydroxyanthraquinone-type dyes to liquid petroleum; combination of dyes for digitally coding/marking petroleum products; near-infrared absorption ROHM AND HAAS COMPANY (US) 2011-03-29 US disclosed
US-20100159279-A1 OLIGOANILINE COMPOUNDS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-24 US disclosed
US-20100159279-A1 OLIGOANILINE COMPOUNDS NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-24 US disclosed
US-20090291467-A1 Near Infrared Fluorophore for the Selective Labelling of Membranes in Cells UNIVERSITAT HEIDELBERG (DE) 2009-11-26 US disclosed
US-7544308-B2 Dichroic dye and microencapsulated liquid crystal composition thereof INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2009-06-09 US disclosed
EP-2062870-A1 OLIGOANILINE COMPOUNDS Nissan Chemical Industries, Ltd. (JP) 2009-05-27 EP disclosed
CN-1315883-C Polymerisation catalyst BP CHEM INT LTD (GB) 2007-05-16 CN disclosed
CN-1239447-C Organic electroluminescent material UNIV TSINGHUA (CN) 2006-02-01 CN disclosed
US-20050227860-A1 Polymerisation catalyst BP CHEMICALS LIMITED (GB) 2005-10-13 US disclosed
CN-1649910-A Polymerization catalyst BP CHEM INT LTD (GB) 2005-08-03 CN disclosed
EP-1497342-A2 POLYMERISATION CATALYST BP Chemicals Limited (GB) 2005-01-19 EP disclosed
US-20040087436-A1 Novel polymerisation catalysts BP CHEMICALS LIMITED (GB) 2004-05-06 US disclosed
EP-1362068-A2 NOVEL POLYMERISATION CATALYSTS BP Chemicals Limited (GB) 2003-11-19 EP disclosed
WO-2003091292-A2 POLYMERISATION CATALYST BP CHEMICALS LIMITED (GB) 2003-11-06 WO disclosed
CN-1362464-A Organic electroluminescent material UNIV QINGHUA (CN) 2002-08-07 CN disclosed
WO-2002050138-A2 NOVEL POLYMERISATION CATALYSTS BP CHEMICALS LIMITED (GB) 2002-06-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100159279-A1 OLIGOANILINE COMPOUNDS CRY2, H1-10, H1-2 NQO1 1243/4885POR 998/4885NSD2 703/4885
US-20150307441-A1 NEW COMPOUNDS AND USES THEREOF HIF1AN, HIF1A, EGLN2 NQO1 27/4885POR 680/4885NSD2 1922/4885
US-20040087436-A1 Novel polymerisation catalysts SCO2, PDS5A, MT-CO3 NQO1 219/4885POR 106/4885NSD2 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.